Abstract:BACKGROUND & AIMS:Hepatic ischaemia-reperfusion (I/R) injury is characterised by severe inflammation and extensive cell death. Multiple signalling pathways, including NF-κB and mitogen-activated protein kinase (MAPK)/c-Jun NH2-terminal kinase (JNK), have important roles in this process. Identifying the unknown critical regulators of these signalling pathways could provide potential targets for therapeutic application. Dual-specificity phosphatase 14 (DUSP14) acts as a negative regulator of NF-κB signalling. However, its function in hepatic I/R injury is unknown. METHODS:Hepatocyte-specific Dusp14 knockout (HKO) and transgenic (TG) mice were subjected to hepatic I/R surgery to examine Dusp14 function in vivo. Primary hepatocytes isolated from Dusp14-HKO and Dusp14-TG mice were cultured and subjected to hypoxia/reoxygenation insult in vitro. Inflammatory cytokine production was measured using quantitative reverse transcription PCR and ELISA. Liver damage was analysed using histopathology. Co-immunoprecipitation and pull-down assays followed by Western blot were performed to detect Dusp14 and transforming growth factor (Tgf)-β-activated kinase 1 (Tak1) interactions. RESULTS:Dusp14 was significantly downregulated in liver tissues from liver transplantation patients and mice subjected to hepatic I/R surgery. Dusp14-HKO and Dusp14-TG mouse models demonstrated that Dusp14 reduced cell death, ameliorated inflammation, and promoted hepatocyte proliferation and/or regeneration. Dusp14 also suppressed NF-κB and MAPK signalling via a physical interaction with Tak1, leading to its subsequent inhibition. Tak1 inhibition by 5Z-7-ox abolished Dusp14 function in vivo, indicating that TAK1 is required for Dusp14 function in hepatic I/R injury. Finally, mutant Dusp14 lost the ability to bind Tak1 and failed to protect against hepatic I/R injury. CONCLUSIONS:Dusp14 is a protective factor in hepatic I/R injury, and the Dusp14-Tak1-Jnk1/2 regulatory axis is important for the pathogenesis of hepatic I/R injury. Modulation of this axis could be a novel therapeutic strategy to prevent or interfere with this pathological process. LAY SUMMARY:Reductions in the level of the protein Dusp14 are closely associated with liver damage caused by inadequate blood supply followed by restoration of blood flow to the liver. Dusp14 protects against liver damage by suppressing the activity of Tak1. Targeting Dusp14 could be a strategy for prevention and treatment of this disease.

Dusp14 protects against hepatic ischaemia-reperfusion injury via Tak1 suppression.

Hepatocyte DUSP14 Maintains Metabolic Homeostasis and Suppresses Inflammation in the Liver

Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway

DUSP1 Alleviates Cardiac Ischemia/reperfusion Injury by Suppressing the Mff-required Mitochondrial Fission and Bnip3-related Mitophagy Via the JNK Pathways

The Ninj1/Dusp1 Axis Contributes to Liver Ischemia Reperfusion Injury by Regulating Macrophage Activation and Neutrophil Infiltration

Dual-specificity Phosphatase 26 Protects Against Kidney Injury Caused by Ischaemia-Reperfusion Through Restraint of TAK1-JNK/p38-mediated Apoptosis and Inflammation of Renal Tubular Epithelial Cells

Ubiquitin-Specific Peptidase 10 Protects Against Hepatic Ischaemic/Reperfusion Injury via TAK1 Signalling

Regulator of G‐protein signaling 14 protects the liver from ischemia–reperfusion injury by suppressing TGF‐β‐activated kinase 1 activation

The Ninj1/Dusp1 Axis Contributes to Liver Ischemia Reperfusion Injury by Regulating Macrophage Activation and Neutrophil InfiltrationSummary

Regulator of G-protein signaling 14 protects the liver from ischemia reperfusion injury by suppressing TAK1 activation

DUSP12 ameliorates myocardial ischemia–reperfusion injury through HSPB8‐induced mitophagy

KEAP1-NRF2 Complex in Ischemia-Induced Hepatocellular Damage of Mouse Liver Transplants

Ubiquitin-specific protease 29 attenuates hepatic ischemia-reperfusion injury by mediating TGF-β-activated kinase 1 deubiquitination

The dual-specificity phosphatase DUSP14 negatively regulates tumor necrosis factor- and interleukin-1-induced nuclear factor-κB activation by dephosphorylating the protein kinase TAK1.

The Dual-Specificity Phosphatase Dusp14 Negatively Regulates Tumor Necrosis Factor- And Interleukin-1-Induced Nuclear Factor-Kappa B Activation By Dephosphorylating The Protein Kinase Tak1

Activation of Cyclic Adenosine Monophosphate-Dependent Protein Kinase a Signaling Prevents Liver Ischemia/reperfusion Injury in Mice

Ablation of Dual-Specificity Phosphatase 6 Protects against Nonalcoholic Fatty Liver Disease via Cytochrome P450 4A and Mitogen-Activated Protein Kinase

Usp49 Inhibits Ischemia-Reperfusion-Induced Cell Viability Suppression And Apoptosis In Human Ac16 Cardiomyocytes Through Dusp1-Jnk1/2 Signaling

TAK242 suppresses the TLR4 signaling pathway and ameliorates DCD liver IRI in rats

PPARβ/δ activation protects against hepatic ischaemia-reperfusion injury

Targeting DUSP16/TAK1 Signaling Alleviates Hepatic Dyslipidemia and Inflammation in High Fat Diet (Hfd)-Challenged Mice Through Suppressing JNK MAPK.